Yasuhiro Yuasa - Concepedia

Author

Yasuhiro Yuasa

Also Known As

Hisashi Ishikura, Y Yuasa, Y. Yuasa, YASUHIRO YUASA, Yasuhiro YUASA, Yasuhiro Yuasa, Yasuhiro Yuasa M.D., Ph.D, Yukimasa Hatachi

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Tokushima Red Cross Hospital Tokushima University National Cancer Center Hospital East Shizuoka Cancer Center Aichi Cancer Center

About

Yasuhiro Yuasa is an author at Tokushima Red Cross Hospital specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	284
2	Cell Biology	3	3	159
3	Cellular Physiology	2	2	136
4	Engineering	1	1	106
5	Health Sciences	1	1	106

Yasuhiro Yuasa

Publications

983

Citations

H-Index

Page 1

	Year	Citations
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With <i>RAS</i> Wild-type, Left-Sided Metastatic Colorectal Cancer Jun Watanabe, Kei Muro, Kohei Shitara, JAMA	2023	222
Sequential activation of Raf-1 kinase, mitogen-activated protein (MAP) kinase kinase, MAP kinase, and S6 kinase by hyperosmolality in renal cells. Yoshio Terada, Kimio Tomita, Hiroshi Nonoguchi, Journal of Biological Chemistry Renal PathologyRenal InflammationNephrologyCellular PhysiologyMolecular Pharmacology	1994	116
Sentinel Lymph Node Biopsy Using Intraoperative Indocyanine Green Fluorescence Imaging Navigated with Preoperative CT Lymphography for Superficial Esophageal Cancer Yasuhiro Yuasa, Junichi Seike, Takahiro Yoshida, Annals of Surgical Oncology EngineeringEsophageal CancerMedical ImagingCancer DetectionBiomedical Imaging	2011	106
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer Kohei Shitara, Kei Muro, Jun Watanabe, Nature Medicine	2024	87
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System Chigusa Morizane, Nozomu Machida, Yoshitaka Honma, JAMA Oncology	2022	85
Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study Toshifumi Yamaguchi, Atsuo Takashima, Kengo Nagashima, Gastric Cancer Preoperative ChemotherapyGastrointestinal OncologyAdvanced Gastric CancerMedicineGastroenterology	2020	52
The effect of nutritional support on the immune function in the acute postoperative period after esophageal cancer surgery: total parenteral nutrition versus enteral nutrition Junichi Seike, Akira Tangoku, Yasuhiro Yuasa, The Journal of Medical Investigation	2011	51
CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma Masakazu Goto, Takahiro Yoshida, Yota Yamamoto, Annals of Surgical Oncology Tumor BiologyEsophageal CancerMedicinePathologyPoor Prognosis	2015	37
A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel/5-FU/CDDP Junichi Seike, Toru Sawada, Naoya Kawakita, International Journal of Surgical Oncology	2011	35
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06) Yutaka Kimura, Masashi Fujii, Toshiki Masuishi, Gastric Cancer	2017	26

Page 1